$2,190,000 of NORTHROP GRUMMAN CORPORATION lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"National Defense Authorization Act for Fiscal Year 2027; FY2027 Defense Appropriations Act; FY2026 Defense Appropriations Act (H.R. 4016, S. 2572); FY2027 Military Construction, Veterans Affairs, and Related Agencies Bill; FY2026 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (H.R. 3944); including provisions related to: National Security Space Programs; Microelectronics; spectrum policy; Air and Missile Defense Programs; Munitions/Solid Rocket Motor; Aviation; Acquisition Policy; Aircraft Programs; Strategic Systems; Continuing Appropriations and Extensions Act, 2027 (H.R. 6500) FY2027 Defense Appropriations Act; FY2026 Defense Appropriations Act (H.R. 4016, S. 2572); National Defense Authorization Act for Fiscal Year 2027; NASA Reauthorization Act of 2026 (H.R. 7273); NASA Transition Authorization Act of 2025 (S.933) Implementation of Relief in the One Big Beautiful Bill Act (H.R.1) from Amortization of Qualified Research and Experimentation Expenses Export Control Reform, Foreign Military Sales, Defense Trade, International Sales; National Defense Authorization Act for Fiscal Year 2027 National Defense Authorization Act for Fiscal Year 2027; Intelligence Authorization Act for Fiscal Year 2026 (S. 2342, H.R. 5167) FY2027 Defense Appropriations Act; FY2026 Defense Appropriations Act (H.R. 4016, S.2572) Reprogrammings, Budget Resolution/Reconciliation FY2027 Commerce, Justice, Science Appropriations Act; NASA Reauthorization Act of 2026 (H.R. 7273); NASA Transition Authorization Act of 2025 (S. 933); Continuing Appropriations and Extensions Act, 2027 (H.R. 6500)"
You can find more data on corporate lobbying on Quiver Quantitative.
NOC Insider Trading Activity
NOC insiders have traded $NOC stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $NOC stock by insiders over the last 6 months:
- MARK A III WELSH has made 0 purchases and 21 sales selling 190 shares for an estimated $106,324.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
NOC Hedge Fund Activity
We have seen 807 institutional investors add shares of NOC stock to their portfolio, and 833 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 1,829,766 shares (-26.5%) from their portfolio in Q2 2026, for an estimated $931,918,121
- JPMORGAN CHASE & CO added 1,400,270 shares (+inf%) to their portfolio in Q2 2026, for an estimated $713,171,513
- CAPITAL INTERNATIONAL INVESTORS removed 1,243,791 shares (-17.5%) from their portfolio in Q2 2026, for an estimated $633,475,194
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,156,101 shares (+31831.0%) to their portfolio in Q2 2026, for an estimated $588,813,800
- BLACKROCK, INC. added 901,299 shares (+8.3%) to their portfolio in Q2 2026, for an estimated $459,040,593
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 881,615 shares (+inf%) to their portfolio in Q2 2026, for an estimated $449,015,335
- FMR LLC removed 801,654 shares (-38.1%) from their portfolio in Q2 2026, for an estimated $408,290,398
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
NOC Price Targets
Multiple analysts have issued price targets for $NOC recently. We have seen 2 analysts offer price targets for $NOC in the last 6 months, with a median target of $583.5.
Here are some recent targets:
- John Godyn from Citigroup set a target price of $587.0 on 07/01/2026
- Sheila Kahyaoglu from Jefferies set a target price of $580.0 on 06/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
